Earnings — page 5
Neighborhood Intelligence’s Third-Quarter Revenue Rises 98% on Acquisitions
Third-quarter revenue reached $509 million as core e-commerce rose about 9% and Overstock.com sales increased 75%.
Nu Skin Cuts 2026 Outlook After Third-Quarter Loss
Revenue was $311.0 million, down 14.6%, and the company now sees full-year sales of $1.26 billion to $1.29 billion.
NexPoint Real Estate Finance Swings to a Third-Quarter Loss
Cash available for distribution was $14.0 million, or $0.60 a share, as the company guided fourth-quarter CAD of $0.555 a share at the midpoint.
NLI Swings to Profit as Kronos Sales Growth Accelerates
Net income attributable to stockholders was $12.7 million, or $.26 a share, after a $7.8 million loss a year earlier.
Nkarta Narrows Loss After Second-Quarter Lease Impairment
The biotech posted a $33.3 million net loss, or $0.45 a share, as it scheduled NKX019 data for ACR Convergence 2026.
Marzetti Cyclospora Outbreak Cuts First-Quarter Profit
Diluted earnings fell to $1.07 a share as the outbreak trimmed both segments and gross profit dropped to $110.8 million.
MBIA Swings to Third-Quarter Adjusted Loss on National's PREPA Charges
The guarantor posted a $3 million adjusted net loss, or $(0.06) a diluted share, for the third quarter of 2026, as National's Puerto Rico Electric Power Authority exposure flipped losses and LAE to an expense.
Lifetime Brands Cuts 2026 Operating Income Outlook
Third-quarter net sales were $177.7 million as the company lowered full-year income-from-operations guidance to $42.5 million–$45 million.
Kingsway Posts First Organic Growth Metrics After Earnings Drop
Consolidated adjusted EBITDA was $2.0 million in the third quarter, down from $5.2 million in the second quarter, as Kingsway disclosed organic segment growth for the first time.
Korro Starts First-In-Human Dosing of KRRO-121
The company said cash of $124.8 million as of September 30, 2026 will fund operations into the second half of 2028.
Keros Posts Profit After Takeda License Revenue
The company reported $40.0 million of license revenue and $14.2 million of net income for the quarter ended September 30, 2026.
Kelly's Underlying Revenue Turns Positive After Two Declines
The specialty talent firm posted $927.2 million of third-quarter revenue, with underlying sales up 2.3% after a year-over-year decline that had narrowed for two straight quarters.
Iron Mountain Posts Record Third-Quarter Adjusted EBITDA
Adjusted EBITDA reached a record $748 million, up 13.3%, as the company set full-year revenue guidance of $7,950 million to $8,020 million.
Inspired Cuts 2026 EBITDA Target After Brazil Gaming Halt
Third-quarter revenue was $61.4 million and the Adjusted EBITDA margin reached a quarterly record of 46% excluding periods with a UK VAT rebate as the company lowered its full-year Adjusted EBITDA range to $109 million–$112 million.
InfuSystem Pro Forma Growth Accelerates to 10.2%
The healthcare services company posted $37.6 million of third-quarter revenue and $9.4 million of Adjusted EBITDA, and reaffirmed 6% to 8% full-year pro-forma growth.
Horizon's Debt Yield Falls as NAV Drops to $5.56
Net investment income was $12.3 million, or $0.19 a share, as the company funded nine loans totaling $98.4 million and booked $29.1 million of unrealized depreciation.
Holley Reports Third-Quarter Sales Growth, Hits 3.5x Leverage Target a Quarter Early
Net sales were $141.6 million in the third quarter, and the company cut debt $25 million to reach a four-year-low 3.50x leverage ratio.
Health Catalyst Reaffirms 2026 Outlook After Vitalware Sale
Third-quarter revenue was $56.28 million as the company closed the Vitalware sale and reaffirmed full-year revenue of $246 million to $249 million.
GSI Technology Misses Gross-Margin Guidance on Mix and Costs
Second-quarter fiscal 2027 net revenue was $6.0 million, inside the $5.7 million to $6.5 million range, while gross margin fell to 48.5% from 53.4% in the prior quarter.
Friedman Posts Record Sales and Earnings
Net sales reached a record $286.8 million in the quarter ended September 30, 2026, and net earnings were $15.6 million, or $2.19 a share.
Funko Reiterates 2026 Outlook After Third-Quarter Sales Slow
Third-quarter net sales were $258.3 million, up 3.0%, as Core Collectibles rose 4.8% and Loungefly fell 9.8%.
1-800-Flowers Updates Fiscal 2027 Outlook After Site Sales
The gifting company now expects fiscal 2027 revenue to fall 2% to 5% and Adjusted EBITDA of about $10 million to $15 million after dropping PersonalizationMall.com and Things Remembered.
FTAI Infrastructure Posts Record Adjusted EBITDA of $95.3 Million
The infrastructure investor reported record third-quarter 2026 Adjusted EBITDA of $95.3 million, received regulatory approval to sell Long Ridge and agreed to acquire energy logistics assets from USD Group for $255 million.
Fate Therapeutics Cuts Third-Quarter Loss to 25 Cents a Share
Cash and investments were $139.1 million as of September 30, 2026, and a $15.0 million CIRM grant is expected to extend the runway to mid-2028.
Fastenal Operating Margin Reaches 21.5% as Sales Growth Accelerates
Daily sales rose 15.5% in the third quarter, and operating margin expanded 90 basis points year over year to 21.5%.
Expensify Raises 2026 Free Cash Flow Outlook
The expense-management company now estimates full-year free cash flow of $13.5 million to $15.5 million after $3.3 million of free cash flow in the third quarter.
Energy Transfer Lifts 2026 EBITDA Outlook After Record Volumes
Third-quarter Adjusted EBITDA was $5.03 billion, and the partnership now sees full-year 2026 Adjusted EBITDA of $19.7 billion to $19.9 billion.
eGain Revenue Beats High End of Guidance
Fiscal 2027 first-quarter revenue was $21.9 million, above the high end of the company's outlook, as AI customer revenue reached $14.4 million.
Duke Energy Narrows 2026 Adjusted EPS Range
Third-quarter adjusted earnings were $1.99 a share, and the company said year-to-date results position it near the top of a $6.70-to-$6.80 range.
Caribou Reports Narrower Third-Quarter Net Loss, Plans to Halt Vispa-cel and CB-011
The company posted $1.6 million in licensing and other third-party revenue and a $26.6 million GAAP net loss, or $0.25 a share, in the three months ended September 30, 2026. It does not intend to provide further updates on strategic alternatives unless and until the board approves a course of action, the review concludes, or disclosure is otherwise determined to be appropriate or required.
Cooper-Standard Cuts 2026 Adjusted EBITDA Outlook
The supplier now sees full-year adjusted EBITDA of $235 million to $245 million after $148.8 million of third-quarter awards.
Conduent Reverses EBITDA Decline, Reaffirms 2026 Outlook
Adjusted EBITDA from continuing operations rose to $36 million in the third quarter as the company closed the Transit sale and reaffirmed full-year Adjusted EBITDA of $140 million to $170 million.
Commerce.com Revenue Turns Down After Two Quarters of Growth
Third-quarter revenue was $84.2 million, down 2.1% from a year earlier, as the company posted a $3.2 million GAAP net loss and launched a cost-cutting plan.
Clean Energy Raises 2026 Adjusted EBITDA Outlook
The company lifted its 2026 adjusted EBITDA range to $75 million–$80 million after third-quarter adjusted EBITDA of $27.2 million and a swing in RNG upstream.
Citizens Direct Premiums Rise 7% as Earnings Turn to Loss
Direct insurance premiums reached $50 million in the third quarter, up 7% from a year earlier, as first-year sales extended a sixteen-quarter year-over-year streak.
Cigna Raises 2026 Adjusted Outlook to at Least $30.60 a Share
Third-quarter total revenues rose 6% to $73.7 billion as the company lifted its full-year adjusted income target by $0.15 a share.
Camp4 Completes Global ASCEND Clearances, Targets Year-End Dosing
Cash and cash equivalents stood at $124.5 million as of September 30, 2026, after a $50.1 million second private-placement closing, with the company saying funds are expected to last through the end of 2028.
Cardinal Health Lifts Fiscal 2027 Non-GAAP EPS Outlook
The pharmaceutical distributor reported first-quarter fiscal 2027 revenue of $67.5 billion and raised its full-year non-GAAP EPS range to $12.80 to $13.00.
BRT's Third-Quarter Net Loss Widens as Joint-Venture Loss Grows
Third-quarter 2026 consolidated revenue was $24.735 million. Funds from operations were $0.26 a share and adjusted FFO $0.31 a share, with combined portfolio NOI at $15.1 million.
Blend's Third-Quarter Revenue Growth Falls to 1%
The digital banking platform posted $32.9 million of third-quarter revenue and $4.9 million of non-GAAP operating income, and guided fourth-quarter revenue to $27.7 million–$29.7 million.
BioAge Completes QUELL-CV Enrollment, Doses First DME Patient
The company posted a $33.5 million net loss, or $0.73 a share, as BGE-102 trial costs lifted research spending to $30.2 million.
BD Lifts Fourth-Quarter Growth After Life Sciences Spin
Fourth-quarter revenue reached $5.27 billion, up 5.4% as reported and 5.6% foreign-currency neutral, with adjusted diluted EPS of $4.15.
Biodesix Cuts 2026 Outlook After Growth Slows
Third-quarter revenue was $24.0 million, up 10% from a year earlier, as the company lowered full-year guidance to $101 million to $103 million.
AerSale Reverses Second-Quarter Revenue Decline
Third-quarter revenue was $91.6 million, up 28.6% from a year earlier, after a 33.9% year-over-year drop in the second quarter.
Air Products Posts $13.45 Adjusted EPS and 2027 Range
The industrial gases company posted fiscal 2026 adjusted earnings of $13.45 a share, 12 percent higher, and guided fiscal 2027 adjusted EPS to $14.15 to $14.50.
Akebia Vafseo Sales Reverse After Sequential Gain
Vafseo net product revenue was $14.8 million in the third quarter, down from $21.3 million in the second quarter, as patients reached about 11,500.
Xperi Third-Quarter Media Platform Revenue Doubles as Advertising Growth Accelerates
Advertising and related revenue reached $14.9 million in the third quarter as Media Platform revenue doubled year-over-year.
Viemed Raises 2026 Revenue Floor After Record Quarter
Net revenue hit a record $80.7 million in the third quarter as attributable net income reached $4.6 million, or $0.11 a share.
Unisys Raises 2026 Constant-Currency Revenue Outlook
Third-quarter revenue was $471.5 million, up 2.5% year over year, and the company lifted full-year constant-currency growth guidance to a 3.0% to 1.5% decline.
Uber's Constant-Currency Bookings Growth Cools to 20%
Gross bookings reached $59.8 billion in the third quarter as non-GAAP operating income hit a record 3.9% of bookings.